Search

Nandakumar S Narayanan

Rurality Modifies the Association Between Symptoms and the Diagnosis of Amyotrophic Lateral Sclerosis
Glycolysis-enhancing alpha1-adrenergic antagonists modify cognitive symptoms related to Parkinson's disease
Use of Glycolysis-Enhancing Drugs and Risk of Parkinson's Disease
COVID-19 case fatality and Alzheimer’s disease
A pilot to assess target engagement of terazosin in Parkinson's disease
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease
Patterns of medication use and imaging following initial diagnosis of sarcoidosis
Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases

This work is licensed under CC BY NC SA 4.0

Generated by Hugo with the Academic, maintained with blogdown.